HEADER MEMBRANE PROTEIN, PROTEIN BINDING 07-DEC-06 2O6C TITLE STRUCTURE OF SELENOMETHIONYL RTP34 FROM TREPONEMA PALLIDUM COMPND MOL_ID: 1; COMPND 2 MOLECULE: 34 KDA MEMBRANE ANTIGEN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PATHOGEN-SPECIFIC MEMBRANE ANTIGEN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TREPONEMA PALLIDUM; SOURCE 3 ORGANISM_TAXID: 160; SOURCE 4 GENE: TPD; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: XL1-BLUE; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PPROEXHTA KEYWDS IG-FOLD, SYPHILIS, METAL-ION BINDING, DIMER, MEMBRANE PROTEIN, KEYWDS 2 PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR M.MACHIUS,C.A.BRAUTIGAM,R.K.DEKA,D.R.TOMCHICK,S.B.LUMPKINS, AUTHOR 2 M.V.NORGARD REVDAT 6 27-DEC-23 2O6C 1 REMARK REVDAT 5 20-OCT-21 2O6C 1 REMARK SEQADV LINK REVDAT 4 13-JUL-11 2O6C 1 VERSN REVDAT 3 24-FEB-09 2O6C 1 VERSN REVDAT 2 01-MAY-07 2O6C 1 JRNL REVDAT 1 26-DEC-06 2O6C 0 JRNL AUTH R.K.DEKA,C.A.BRAUTIGAM,F.L.TOMSON,S.B.LUMPKINS,D.R.TOMCHICK, JRNL AUTH 2 M.MACHIUS,M.V.NORGARD JRNL TITL CRYSTAL STRUCTURE OF THE TP34 (TP0971) LIPOPROTEIN OF JRNL TITL 2 TREPONEMA PALLIDUM: IMPLICATIONS OF ITS METAL-BOUND STATE JRNL TITL 3 AND AFFINITY FOR HUMAN LACTOFERRIN. JRNL REF J.BIOL.CHEM. V. 282 5944 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17192261 JRNL DOI 10.1074/JBC.M610215200 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 38740 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3863 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2344 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.67 REMARK 3 BIN R VALUE (WORKING SET) : 0.3050 REMARK 3 BIN FREE R VALUE SET COUNT : 275 REMARK 3 BIN FREE R VALUE : 0.3370 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2485 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 221 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 23.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.09000 REMARK 3 B22 (A**2) : -1.07000 REMARK 3 B33 (A**2) : -0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.111 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.107 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.069 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.089 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2632 ; 0.015 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3583 ; 2.011 ; 1.934 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 323 ; 5.091 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 139 ;33.928 ;24.820 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 381 ;14.500 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;20.402 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 342 ; 0.139 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2445 ; 0.014 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1110 ; 0.189 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1717 ; 0.319 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 183 ; 0.138 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 31 ; 0.167 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.134 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1622 ; 1.302 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2555 ; 1.788 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1153 ; 2.791 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1028 ; 4.416 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 28 A 185 REMARK 3 ORIGIN FOR THE GROUP (A): 10.8892 41.3041 61.4519 REMARK 3 T TENSOR REMARK 3 T11: -0.0941 T22: -0.0057 REMARK 3 T33: -0.0273 T12: 0.0047 REMARK 3 T13: -0.0077 T23: -0.0419 REMARK 3 L TENSOR REMARK 3 L11: 0.4497 L22: 1.2875 REMARK 3 L33: 1.5910 L12: 0.3241 REMARK 3 L13: 0.7853 L23: 0.8214 REMARK 3 S TENSOR REMARK 3 S11: -0.0099 S12: -0.0339 S13: 0.0082 REMARK 3 S21: -0.1420 S22: 0.0436 S23: 0.0097 REMARK 3 S31: -0.0209 S32: 0.0189 S33: -0.0337 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 29 B 185 REMARK 3 ORIGIN FOR THE GROUP (A): 6.4390 14.8969 52.3489 REMARK 3 T TENSOR REMARK 3 T11: 0.0825 T22: -0.0881 REMARK 3 T33: -0.0582 T12: -0.0219 REMARK 3 T13: -0.1119 T23: 0.0028 REMARK 3 L TENSOR REMARK 3 L11: 0.7633 L22: 1.8678 REMARK 3 L33: 1.6773 L12: 0.8534 REMARK 3 L13: 0.8336 L23: 1.7691 REMARK 3 S TENSOR REMARK 3 S11: 0.2190 S12: -0.1041 S13: -0.1284 REMARK 3 S21: 0.2225 S22: -0.0041 S23: -0.1067 REMARK 3 S31: 0.3619 S32: -0.0805 S33: -0.2149 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2O6C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-DEC-06. REMARK 100 THE DEPOSITION ID IS D_1000040742. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97943 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CUSTOM-MADE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38808 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 23.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 14.30 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07600 REMARK 200 FOR THE DATA SET : 39.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.3 REMARK 200 DATA REDUNDANCY IN SHELL : 7.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.78200 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.4 M AMMONIUM SULFATE, 0.1 M BICINE, REMARK 280 PH 9.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 17.20500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.49600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.01000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.49600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 17.20500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.01000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -76.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 ALA A -2 REMARK 465 MSE A -1 REMARK 465 GLY A 0 REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 465 GLY A 3 REMARK 465 GLY A 4 REMARK 465 GLY A 5 REMARK 465 GLU A 6 REMARK 465 HIS A 7 REMARK 465 GLN A 8 REMARK 465 HIS A 9 REMARK 465 GLY A 10 REMARK 465 GLU A 11 REMARK 465 GLU A 12 REMARK 465 MSE A 13 REMARK 465 MSE A 14 REMARK 465 ALA A 15 REMARK 465 ALA A 16 REMARK 465 VAL A 17 REMARK 465 PRO A 18 REMARK 465 ALA A 19 REMARK 465 PRO A 20 REMARK 465 ASP A 21 REMARK 465 ALA A 22 REMARK 465 GLU A 23 REMARK 465 GLY A 24 REMARK 465 ALA A 25 REMARK 465 ALA A 26 REMARK 465 GLY A 27 REMARK 465 GLY B -3 REMARK 465 ALA B -2 REMARK 465 MSE B -1 REMARK 465 GLY B 0 REMARK 465 SER B 1 REMARK 465 GLY B 2 REMARK 465 GLY B 3 REMARK 465 GLY B 4 REMARK 465 GLY B 5 REMARK 465 GLU B 6 REMARK 465 HIS B 7 REMARK 465 GLN B 8 REMARK 465 HIS B 9 REMARK 465 GLY B 10 REMARK 465 GLU B 11 REMARK 465 GLU B 12 REMARK 465 MSE B 13 REMARK 465 MSE B 14 REMARK 465 ALA B 15 REMARK 465 ALA B 16 REMARK 465 VAL B 17 REMARK 465 PRO B 18 REMARK 465 ALA B 19 REMARK 465 PRO B 20 REMARK 465 ASP B 21 REMARK 465 ALA B 22 REMARK 465 GLU B 23 REMARK 465 GLY B 24 REMARK 465 ALA B 25 REMARK 465 ALA B 26 REMARK 465 GLY B 27 REMARK 465 PHE B 28 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 169 CD GLU A 169 OE2 0.101 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 78 -168.60 -102.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA B 80 GLY B 81 59.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2O6D RELATED DB: PDB REMARK 900 RELATED ID: 2O6E RELATED DB: PDB REMARK 900 RELATED ID: 2O6F RELATED DB: PDB DBREF 2O6C A -3 185 UNP P19478 TA34_TREPA 16 204 DBREF 2O6C B -3 185 UNP P19478 TA34_TREPA 16 204 SEQADV 2O6C GLY A -3 UNP P19478 VAL 16 ENGINEERED MUTATION SEQADV 2O6C ALA A -2 UNP P19478 PHE 17 ENGINEERED MUTATION SEQADV 2O6C MSE A -1 UNP P19478 SER 18 ENGINEERED MUTATION SEQADV 2O6C GLY A 0 UNP P19478 ALA 19 ENGINEERED MUTATION SEQADV 2O6C SER A 1 UNP P19478 CYS 20 ENGINEERED MUTATION SEQADV 2O6C MSE A 13 UNP P19478 MET 32 MODIFIED RESIDUE SEQADV 2O6C MSE A 14 UNP P19478 MET 33 MODIFIED RESIDUE SEQADV 2O6C MSE A 54 UNP P19478 MET 73 MODIFIED RESIDUE SEQADV 2O6C MSE A 113 UNP P19478 MET 132 MODIFIED RESIDUE SEQADV 2O6C MSE A 117 UNP P19478 MET 136 MODIFIED RESIDUE SEQADV 2O6C GLY B -3 UNP P19478 VAL 16 ENGINEERED MUTATION SEQADV 2O6C ALA B -2 UNP P19478 PHE 17 ENGINEERED MUTATION SEQADV 2O6C MSE B -1 UNP P19478 SER 18 ENGINEERED MUTATION SEQADV 2O6C GLY B 0 UNP P19478 ALA 19 ENGINEERED MUTATION SEQADV 2O6C SER B 1 UNP P19478 CYS 20 ENGINEERED MUTATION SEQADV 2O6C MSE B 13 UNP P19478 MET 32 MODIFIED RESIDUE SEQADV 2O6C MSE B 14 UNP P19478 MET 33 MODIFIED RESIDUE SEQADV 2O6C MSE B 54 UNP P19478 MET 73 MODIFIED RESIDUE SEQADV 2O6C MSE B 113 UNP P19478 MET 132 MODIFIED RESIDUE SEQADV 2O6C MSE B 117 UNP P19478 MET 136 MODIFIED RESIDUE SEQRES 1 A 189 GLY ALA MSE GLY SER GLY GLY GLY GLY GLU HIS GLN HIS SEQRES 2 A 189 GLY GLU GLU MSE MSE ALA ALA VAL PRO ALA PRO ASP ALA SEQRES 3 A 189 GLU GLY ALA ALA GLY PHE ASP GLU PHE PRO ILE GLY GLU SEQRES 4 A 189 ASP ARG ASP VAL GLY PRO LEU HIS VAL GLY GLY VAL TYR SEQRES 5 A 189 PHE GLN PRO VAL GLU MSE HIS PRO ALA PRO GLY ALA GLN SEQRES 6 A 189 PRO SER LYS GLU GLU ALA ASP CYS HIS ILE GLU ALA ASP SEQRES 7 A 189 ILE HIS ALA ASN GLU ALA GLY LYS ASP LEU GLY TYR GLY SEQRES 8 A 189 VAL GLY ASP PHE VAL PRO TYR LEU ARG VAL VAL ALA PHE SEQRES 9 A 189 LEU GLN LYS HIS GLY SER GLU LYS VAL GLN LYS VAL MSE SEQRES 10 A 189 PHE ALA PRO MSE ASN ALA GLY ASP GLY PRO HIS TYR GLY SEQRES 11 A 189 ALA ASN VAL LYS PHE GLU GLU GLY LEU GLY THR TYR LYS SEQRES 12 A 189 VAL ARG PHE GLU ILE ALA ALA PRO SER HIS ASP GLU TYR SEQRES 13 A 189 SER LEU HIS ILE ASP GLU GLN THR GLY VAL SER GLY ARG SEQRES 14 A 189 PHE TRP SER GLU PRO LEU VAL ALA GLU TRP ASP ASP PHE SEQRES 15 A 189 GLU TRP LYS GLY PRO GLN TRP SEQRES 1 B 189 GLY ALA MSE GLY SER GLY GLY GLY GLY GLU HIS GLN HIS SEQRES 2 B 189 GLY GLU GLU MSE MSE ALA ALA VAL PRO ALA PRO ASP ALA SEQRES 3 B 189 GLU GLY ALA ALA GLY PHE ASP GLU PHE PRO ILE GLY GLU SEQRES 4 B 189 ASP ARG ASP VAL GLY PRO LEU HIS VAL GLY GLY VAL TYR SEQRES 5 B 189 PHE GLN PRO VAL GLU MSE HIS PRO ALA PRO GLY ALA GLN SEQRES 6 B 189 PRO SER LYS GLU GLU ALA ASP CYS HIS ILE GLU ALA ASP SEQRES 7 B 189 ILE HIS ALA ASN GLU ALA GLY LYS ASP LEU GLY TYR GLY SEQRES 8 B 189 VAL GLY ASP PHE VAL PRO TYR LEU ARG VAL VAL ALA PHE SEQRES 9 B 189 LEU GLN LYS HIS GLY SER GLU LYS VAL GLN LYS VAL MSE SEQRES 10 B 189 PHE ALA PRO MSE ASN ALA GLY ASP GLY PRO HIS TYR GLY SEQRES 11 B 189 ALA ASN VAL LYS PHE GLU GLU GLY LEU GLY THR TYR LYS SEQRES 12 B 189 VAL ARG PHE GLU ILE ALA ALA PRO SER HIS ASP GLU TYR SEQRES 13 B 189 SER LEU HIS ILE ASP GLU GLN THR GLY VAL SER GLY ARG SEQRES 14 B 189 PHE TRP SER GLU PRO LEU VAL ALA GLU TRP ASP ASP PHE SEQRES 15 B 189 GLU TRP LYS GLY PRO GLN TRP MODRES 2O6C MSE A 54 MET SELENOMETHIONINE MODRES 2O6C MSE A 113 MET SELENOMETHIONINE MODRES 2O6C MSE A 117 MET SELENOMETHIONINE MODRES 2O6C MSE B 54 MET SELENOMETHIONINE MODRES 2O6C MSE B 113 MET SELENOMETHIONINE MODRES 2O6C MSE B 117 MET SELENOMETHIONINE HET MSE A 54 8 HET MSE A 113 8 HET MSE A 117 8 HET MSE B 54 8 HET MSE B 113 8 HET MSE B 117 8 HET CL A 301 1 HET CL A 302 1 HET CL A 304 1 HET EDO A 401 4 HET EDO A 403 4 HET SO4 B 501 5 HET SO4 B 502 5 HET CL B 303 1 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM SO4 SULFATE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 CL 4(CL 1-) FORMUL 6 EDO 2(C2 H6 O2) FORMUL 8 SO4 2(O4 S 2-) FORMUL 11 HOH *221(H2 O) HELIX 1 1 GLU A 79 GLY A 85 5 7 HELIX 2 2 SER A 148 TYR A 152 5 5 HELIX 3 3 GLU B 79 GLY B 85 5 7 SHEET 1 A 3 PHE A 31 PRO A 32 0 SHEET 2 A 3 LEU A 42 PHE A 49 -1 O TYR A 48 N PHE A 31 SHEET 3 A 3 ARG A 37 VAL A 39 -1 N ARG A 37 O VAL A 44 SHEET 1 B 7 PHE A 31 PRO A 32 0 SHEET 2 B 7 LEU A 42 PHE A 49 -1 O TYR A 48 N PHE A 31 SHEET 3 B 7 CYS A 69 ALA A 77 -1 O HIS A 76 N HIS A 43 SHEET 4 B 7 GLY A 122 VAL A 129 -1 O TYR A 125 N ALA A 73 SHEET 5 B 7 ALA A 115 ALA A 119 -1 N ALA A 115 O GLY A 126 SHEET 6 B 7 SER B 153 HIS B 155 1 O HIS B 155 N ASN A 118 SHEET 7 B 7 MSE A 54 HIS A 55 -1 N HIS A 55 O LEU B 154 SHEET 1 C 4 GLN A 110 MSE A 113 0 SHEET 2 C 4 ARG A 96 LYS A 103 -1 N ALA A 99 O VAL A 112 SHEET 3 C 4 GLY A 136 ALA A 145 -1 O ALA A 145 N ARG A 96 SHEET 4 C 4 LEU A 171 TRP A 180 -1 O ALA A 173 N PHE A 142 SHEET 1 D 3 PHE B 31 PRO B 32 0 SHEET 2 D 3 LEU B 42 PHE B 49 -1 O TYR B 48 N PHE B 31 SHEET 3 D 3 ARG B 37 VAL B 39 -1 N ARG B 37 O VAL B 44 SHEET 1 E 7 PHE B 31 PRO B 32 0 SHEET 2 E 7 LEU B 42 PHE B 49 -1 O TYR B 48 N PHE B 31 SHEET 3 E 7 CYS B 69 ALA B 77 -1 O HIS B 76 N HIS B 43 SHEET 4 E 7 GLY B 122 VAL B 129 -1 O VAL B 129 N CYS B 69 SHEET 5 E 7 ALA B 115 ALA B 119 -1 N ALA B 115 O GLY B 126 SHEET 6 E 7 SER A 153 HIS A 155 1 N HIS A 155 O ASN B 118 SHEET 7 E 7 MSE B 54 HIS B 55 -1 O HIS B 55 N LEU A 154 SHEET 1 F 4 GLN B 110 MSE B 113 0 SHEET 2 F 4 ARG B 96 LYS B 103 -1 N ALA B 99 O VAL B 112 SHEET 3 F 4 GLY B 136 ALA B 145 -1 O GLU B 143 N VAL B 98 SHEET 4 F 4 LEU B 171 TRP B 180 -1 O PHE B 178 N TYR B 138 LINK C GLU A 53 N MSE A 54 1555 1555 1.33 LINK C MSE A 54 N HIS A 55 1555 1555 1.33 LINK C VAL A 112 N MSE A 113 1555 1555 1.33 LINK C MSE A 113 N PHE A 114 1555 1555 1.33 LINK C PRO A 116 N MSE A 117 1555 1555 1.32 LINK C MSE A 117 N ASN A 118 1555 1555 1.33 LINK C GLU B 53 N MSE B 54 1555 1555 1.33 LINK C MSE B 54 N HIS B 55 1555 1555 1.33 LINK C VAL B 112 N MSE B 113 1555 1555 1.32 LINK C MSE B 113 N BPHE B 114 1555 1555 1.32 LINK C MSE B 113 N APHE B 114 1555 1555 1.33 LINK C PRO B 116 N MSE B 117 1555 1555 1.33 LINK C MSE B 117 N ASN B 118 1555 1555 1.34 CISPEP 1 HIS A 55 PRO A 56 0 -12.99 CISPEP 2 HIS B 55 PRO B 56 0 -11.76 SITE 1 AC1 7 ARG A 165 TRP A 167 SER A 168 GLU A 169 SITE 2 AC1 7 HOH A 450 HOH B 514 HOH B 552 SITE 1 AC2 5 GLY B 34 GLU B 35 ARG B 37 TRP B 175 SITE 2 AC2 5 HOH B 580 SITE 1 AC3 1 HIS A 149 SITE 1 AC4 1 ARG A 141 SITE 1 AC5 1 HOH A 514 SITE 1 AC6 8 PHE A 31 PRO A 32 TYR A 48 ASP A 68 SITE 2 AC6 8 LYS A 130 LYS A 181 GLN A 184 HOH A 408 SITE 1 AC7 6 ARG A 37 TRP A 175 ASP A 176 HOH A 425 SITE 2 AC7 6 HOH A 506 HOH A 533 CRYST1 34.410 66.020 150.992 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029061 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015147 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006623 0.00000